This website uses cookies. By using the site you are agreeing to our Privacy Policy.

Top of the page.
Skip the menu to main contents.
Move to main menu.
Skip to main contents.


Main menu starts here.
Skip the main menu to current location in your website.

Current location in your website.
Skip to main contents.

History

 

FUJIFILM Toyama Chemical Co., Ltd.

2018 FUJIFILM RI Pharma merged TOYAMA CHEMICAL.
Company name changed to FUJIFILM Toyama Chemical Co., Ltd.

FUJIFILM RI Pharma Co., Ltd.

1968 December the 5th Founded as a joint venture between Daiichi Seiyaku Group and U. S. Mallinckrodt
1972 Started local production of Ultra-Techne Kow Installed hot cells
1984 Installed a cyclotron
1988 Dissolved the joint venture with Mallinckrodt and became 100% affiliate of Daiichi Seiyaku
1990 Awarded a prize from Science and Technology Agency Minister for radiation safety control (Chiba Factory)
1991 Installed the second cyclotron
1995 Awarded a prize from Kanto International Trade and Industry Director General for a superior production facility with tree-planting (Chiba Factory)
2000 Started the sale of immunodiagnostic products through TFB, Inc.
2002 Approval of Iofetamine (123I) [Daiichi]
2004 Transferred Immunodiagnostic business to TFB, Inc.
2005 Installed the third cyclotron
2006 Became 100% subsidiary of FUJIFILM Corporation in Oct.
2007 FUJIFILM RI Pharma Co., Ltd., New Company started in April.
2010 Started the sale of Resovist transferred from Bayer
2015 Approval of ADENOSINE Injection Syringe FRI
Approval of Octreoscan® Injection
2016 Kawasaki PET Laboratory established
Ibaraki PET Laboratory established
Approval of Amyvid®
2017 Approval of Fludeoxyglucose (18F) Injection FRI

TOYAMA CHEMICAL CO., LTD.

1936 Toyama Chemical Co., Ltd., established around the business of Toyama Chemical Research Laboratory
1961 Head office relocated from Toyama to Nihonbashi, Tokyo
Listed on the second section of the Tokyo Stock Exchange
1970 General Research Laboratory completed
1971 Factory for the manufacture of injectable products completed
1972 Listed on the first section of the Tokyo Stock Exchange
First phase of pharmaceutical factory completed
1975 No. 2 Research Laboratory completed
Second phase of pharmaceutical factory completed
1978 Head office relocated from Nihonbashi to Shinjuku, Tokyo
1979 Approval of PENTCILLIN injection and intramuscular
1980 No. 3 Research Laboratory completed
1981 Approval of ABOVIS capsules
1982 Approval of BAXO capsules
1985 No. 5 Research Laboratory completed
1986 Approval of BAXO ointment
1987 Approval of TOMIRON tablet
1988 Approval of BAXO suppositories
1989 No. 1 Research Laboratory completed
1990 Approval of OZEX tablet
Approval of TOMIRON fine granules
1998 Pharmaceutical factory and distribution wing completed
1999 LUPRAC tablet introduced
2002 HALOSPOR intravenous introduced
Agreed on a strategic capital and business alliance with Taisho Pharmaceutical Co., Ltd.
Approval of PASIL intravenous drip
Taisho Toyama Pharmaceutical Co., Ltd. established
Approval of PENTCILLIN intravenous bag
2006 Approval of OZEX ophthalmic solution
No. 6 Research Laboratory completed
2007 Approval of GENINAX tablet
2008 Agreed on a strategic capital and business alliance between FUJIFILM Holdings Corporation, Taisho Pharmaceutical Co., Ltd. and Toyama Chemical Co., Ltd.
Delisted on the first section of the Tokyo Stock Exchange
Approval of ZOSYN intravenous
2009 Approval of OZEX fine granules
2012 No. 7 Research Laboratory completed
Approval of KOLBET tablet
2013 Factory for the manufacture of injectable products completed
2014 Factory for the manufacture of injectable bag products completed
Approval of AVIGAN tablet
Approval of ZOSYN intravenous bag
2018 Transfer of rights to KOLBET tablet to Eisai Co., Ltd. in Japan
Toyama Chemical Co., Ltd. became 100% subsidiary of FUJIFILM Corporation

Related Information

Operating company that leads the Fujifilm Group's imaging and information solutions.


Footer starts here.

Pages ends here.
Move to top of the page.